Drug discovery research collaboration is announced

Article

Leica Microsystems and Definiens have announced a co-marketing agreement.

Leica Microsystems and Definiens have announced a co-marketing agreement.

Global precision optical system designer and producer Leica Microsystems will market their products with biomedical image analysis developer Definiens. Both firms will host educational events and workshops. Definiens Developer XD will analyze data created by Leica's confocal microscopes.

Thomas P. Heydler, CEO of Definiens, said: “Definiens and Leica Microsystems share a commitment to developing powerful imaging solutions that help researchers understand biological pathways faster and more accurately. This partnership will provide Leica customers with access to Definiens’ advanced image analysis software, enabling high-content screening that directly aids drug discovery efforts around the world.”

Dr Stefan Traeger, Managing Director of the Life Science Division of Leica Microsystems, said: “Together with Definiens, we look forward to the opportunity to make highly developed and future-proof high content screening solutions widely available for academic research as well. The combination of high-sensitivity confocal technology, miniaturized sample handling and reproducible evaluation with optimized data management is a sine qua non among drug discovery strategies and the analysis of their physiological relevance.”

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.